A Potential Mechanism for Immune Suppression by Beta-Adrenergic Receptor Stimulation following Traumatic Injury
- 16 February 2018
- journal article
- research article
- Published by S. Karger AG in Journal of Innate Immunity
- Vol. 10 (3), 202-214
- https://doi.org/10.1159/000486972
Abstract
Background: β-Adrenergic agents suppress inflammation and may play an important role in posttraumatic infections. Mechanisms may include inhibition of MAP kinase signaling. We sought to determine whether MKP-1 contributed to catecholamine suppression of innate immunity and also wanted to know whether early catecholamine treatment after traumatic injury increases the risk of later nosocomial infection. Methods: We performed experiments using THP-1 cells and peripheral blood mononuclear cells from healthy individuals. We exposed cells to epinephrine and/or LPS and measured inflammatory gene transcription and MAP kinase activation. We inhibited MKP-1 activity to determine its role in catecholamine-induced immune suppression. Finally, we studied injured subjects to determine whether early catecholamine treatment was associated with nosocomial infection. Results: Epinephrine increases MKP-1 transcripts and protein and decreases LPS-induced p38 and JNK phosphorylation and TNF-α gene transcription. RNAi inhibition of MKP-1 at least partially restores LPS-induced TNF-α gene expression (p = 0.024). In the clinical cohort, subjects treated with β-adrenergic agents had an increased risk of ventilator-associated pneumonia (aOR = 1.9; 95% CI = 1.3–2.6) and bacteremia (aOR = 1.5; 95% CI = 1.1–2.3). Conclusions: MKP-1 may have a role in catecholamine-induced suppression of innate immunity, and exogenous catecholamines might contribute to nosocomial infection risk.Keywords
This publication has 36 references indexed in Scilit:
- Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism SyndromeCritical Care Medicine, 2017
- Effect of Dialysis Initiation Timing on Clinical Outcomes: A Propensity-Matched Analysis of a Prospective Cohort Study in KoreaPLOS ONE, 2014
- Traumatic Injury, Early Gene Expression, and Gram-Negative Bacteremia*Critical Care Medicine, 2014
- Toll-Like Receptor 1 Polymorphisms and Associated Outcomes in Sepsis After Traumatic InjuryAnnals of Surgery, 2014
- The changing pattern and implications of multiple organ failure after blunt injury with hemorrhagic shock*Critical Care Medicine, 2012
- Triptolide induces anti-inflammatory cellular responses2009
- Early Use of Vasopressors After Injury: Caution Before ConstrictionJournal Of Trauma-Injury Infection and Critical Care, 2008
- Regulation of cAMP-induced arylalkylamine N-acetyltransferase, Period1, and MKP-1 gene expression by mitogen-activated protein kinases in the rat pineal glandMolecular Brain Research, 2005
- Triptolide, A Novel Immunosuppressive and Anti-Inflammatory Agent Purified from a Chinese Herb Tripterygium Wilfordii Hook FLeukemia & Lymphoma, 2001
- Anti-inflammatory effects of triptolide in human bronchial epithelial cellsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2000